Non stimulant medications for ADHD
Pro Research Analysisby 
Searched over 200M research papers
Overview of Non-Stimulant Medications for ADHD
Stimulant medications are the most common treatment for ADHD, but not all patients respond well or tolerate them. For these individuals, non-stimulant medications offer important alternatives for both children and adults with ADHD Banaschewski2004Vilus2025Brancati2024+3 MORE.
Key Non-Stimulant Medication Classes for ADHD
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Atomoxetine is the most widely studied and used non-stimulant for ADHD. It is effective in both children and adults, with a favorable side effect profile and once-daily dosing. Atomoxetine has been shown to improve core ADHD symptoms and executive functions, with effects comparable to stimulants in some cognitive domains Banaschewski2004Brancati2024Dittmann2018+4 MORE. Another SNRI, viloxazine extended-release, is a newer option that has shown promise in recent studies and is now available for pediatric use Vilus2025Nageye2019O’Connor2023.
Alpha-2 Adrenergic Agonists
Guanfacine extended-release and clonidine extended-release are approved non-stimulant options for ADHD. These medications are particularly useful for patients who cannot tolerate stimulants or have certain comorbidities. They can be used alone or in combination with stimulants Vilus2025Brancati2024Dittmann2018+1 MORE.
Other Non-Stimulant Medications and Emerging Options
Tricyclic antidepressants (TCAs) and bupropion have demonstrated efficacy in treating ADHD, but their use is limited by side effects and they are generally considered third-line or off-label options Banaschewski2004Brancati2024Dittmann2018+1 MORE. Newer agents, such as centanafadine (a triple reuptake inhibitor), are in development and may expand future treatment choices Nageye2019O’Connor2023.
Experimental treatments, including cholinergic drugs (like acetylcholinesterase inhibitors and nicotinic analogues), memantine, metadoxine, and mood stabilizers, have shown some potential but require more research before routine use Banaschewski2004Brancati2024Biederman2000+1 MORE.
Efficacy and Considerations
Non-stimulant medications are generally less effective than stimulants for most patients, but they are valuable for those who do not respond to or cannot tolerate stimulants, or when there is a risk of stimulant misuse or diversion Vilus2025Dittmann2018Nageye2019+2 MORE. Atomoxetine and guanfacine are the most established options, with viloxazine emerging as a promising new agent Vilus2025Brancati2024Dittmann2018+2 MORE. Non-stimulants can be used as monotherapy or as adjuncts to stimulants to optimize treatment Vilus2025Dittmann2018.
Conclusion
Non-stimulant medications, including atomoxetine, guanfacine, clonidine, and viloxazine, provide effective alternatives for managing ADHD, especially for patients who cannot use stimulants. While generally less potent than stimulants, these medications are important for personalized treatment approaches and continue to expand with new research and drug development Banaschewski2004Vilus2025Brancati2024+7 MORE.
Sources and full results
Most relevant research papers on this topic